Showing results (181-190 of 283) with videos related to
Sort By:
Pageof 29
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1989
The productive gene for alpha-H chain disease protein MAL is highly modified by insertion-deletion processesA Tsapis, M Bentaboulet, P Pellet, et al.La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|November 9, 1977
[Gamma heavy chain disease associated with rheumatoid arthritis. Spontaneous disappearance of the pathologic protein]A Gaucher, F Bertrand, J C Brouet, et al.Clinical Immunology and Immunopathology|April 1, 1989
Serum IgG subclass levels in patients with primary immunodeficiency syndromes or abnormal susceptibility to infectionsP Aucouturier, C Lacombe, C Bremard, et al.International Journal of Cell Cloning|May 1, 1984
Evaluation of an automated image analysis system for counting human tumor coloniesS E Salmon, L Young, J Lebowitz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1983
Effects of cloned human leukocyte interferons in the human tumor stem cell assayS E Salmon, B G Durie, L Young, et al.Cancer Research|May 15, 1997
Potent pseudosubstrate-based peptide inhibitors for p60(c-src) protein tyrosine kinaseQ Lou, M E Leftwich, R T McKay, et al.Investigational New Drugs|January 1, 1996
Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitorR T Dorr, K Dvorakova, K Snead, et al.Peptide Research|May 1, 1993
Peptide-encoding for structure determination of nonsequenceable polymers within libraries synthesized and tested on solid-phase supportsV Nikolaiev, A Stierandová, V Krchnák, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
Phase I trial of esorubicin (4'deoxydoxorubicin)H S Garewal, A Robertone, S E Salmon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group studyS E Salmon, J J Crowley, T M Grogan, et al.Pageof 29